Sahajanand Medical Technologies Limited IPO DRHP
Sahajanand Medical is engaged in the development of Class III1 and Class C/D2 medical devices, with an emphasis on Vascular Intervention (“VI”)
and Structural Heart (“SH”). Its portfolio of (i) VI products includes coronary intervention products such as coronary stents and
coronary balloons, (ii) SH products includes Trans-Catheter Aortic Valves and Occluders, and (iii) other products including our
own brand of renal stents, peripheral drug coated balloons and other trading products.
Sahajanand Medical IPO Objects
The issue is a complete Offer for Sale (OFS). The company will not receive any funds from the issue, entire proceeds will be received by the Selling Shareholder(s).
Sahajanand Medical IPO Details
Price Band₹ |
Listing AtNSE & BSE |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹0.00 (0.00 Shares) |
Offer For Sale₹0.00 (2.76 Cr Shares) |
Total Issue₹0.00 (2.76 Cr Shares) |
Face Value₹1 per equity share |
Category Allocation
| Particulars | Allocation |
|---|---|
| QIBs | Not more than 50% of Net Offer |
| Big HNIs (NII) | Not less than 10% of Net Offer |
| Small HNIs (NII) | Not less than 5% of Net Offer |
| Retail | Not less than 35% of Net Offer |
Sahajanand Medical IPO Financials
| Particulars | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| Revenue | 1,024.88 | 901.60 | 795.55 |
| PAT | 25.15 | -7.35 | 11.93 |
| Net Worth | 545.23 | 526.30 | 539.21 |
| Borrowings | 224.96 | 175.27 | 132.18 |
| Assets | 1,094.90 | 970.58 | 911.63 |
| NAV (₹) | 55.86 | 54.01 | 55.33 |
| EPS (₹) | 2.09 | -1.31 | 0.84 |
The financial information presented is on a consolidated basis.
Key Performance Indicators
| KPI | VALUES |
|---|---|
| EBITDA | 12.49% |
| PAT | 2.45% |
| ROE | 3.68% |
| ROCE | 10.37% |
All the data pertains to FY 2024-25. PE, PB, and market capitalization are calculated based on the Upper Price Band.
Promoter Details
| Name | Shareholding |
|---|---|
| Shree Hari Trust | 36.79% |
| Dhirajkumar Savjibhai Vasoya | 4.03% |
| Others | 0.10% |
| Total | 40.92% |
Management Details
| Name | Designation |
|---|---|
| Jose Calle Gordo | Chairman |
| Bhargav Dhirajlal Kotadia | MD |
| Amit Kumar Khandelia | CFO |
Company Details
Name: Sahajanand Medical Technologies Limited
Address: Sahajanand Estate,
Wakharia Wadi, NR.
Dabholi Char Rasta, Nani
Ved, Ved Road, Surat,
Gujarat – 395 004, India
Number: 022 49564000
Email: investors.grievance@smt.in
Website: www.smtpl.com
Book Running Lead Managers (BRLMs)
RTAs
MUFG Intime India
Visit WebsiteFrequently Asked questions?
Find answers to common questions that come in your mind related to IPO.
Sahajanand Medical IPO is a Mainboard IPO having an issue size of Rs. ₹0.00 Crs. Sahajanand Medical IPO is priced at ₹ - ₹ per share. The issue opens on 11 Feb 26 and closes on 11 Feb 26.
Sahajanand Medical IPO opens on 11 Feb 26 and closes on 11 Feb 26.
The estimated Grey Market Premium of Sahajanand Medical IPO is ₹0 per share (-).
The minimum lot size of Sahajanand Medical IPO is shares & the minimum application amount is Rs. 0.
The allotment date of Sahajanand Medical IPO is 11 Feb 26.
The listing date of Sahajanand Medical IPO is 11 Feb 26.
Sahajanand Medical IPO is subscribed -.
Sahajanand Medical IPO is priced at ₹ - ₹ per share.
Click the allotment link on Sahajanand Medical IPO page of IPO360.
- Go to Kite App → Tap on Bids → Tap on IPO
- Select the IPO → Tap on apply → Enter UPI ID
- Enter Qty and Price
- Submit the application
- Approve the UPI Mandate on your UPI app
- Go to Groww App → Stocks Section → Select IPO option
- Select the IPO you want to apply
- Enter your bid details and price
- Enter UPI ID & submit
- Approve the UPI Mandate on your UPI app
- Log in to your bank's net banking portal.
- Navigate to the 'IPO' or 'ASBA' section.
- Select Sahajanand Medical IPO from the list of available IPOs.
- Enter the required details: Bid quantity, Price, DP ID & Client ID, etc
- Submit the application.
- Money will remain blocked till the refund date
